Global Surgical Heart Valve Management Products Market Insights, Forecast to 2028

Market Analysis and Insights: Global Surgical Heart Valve Management Products Market
Due to the COVID-19 pandemic, the global Surgical Heart Valve Management Products market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Percutaneous Balloon Valvuloplasty  accounting for % of the Surgical Heart Valve Management Products global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Surgical Heart Valve Management Products market size is valued at US$ million in 2021, while the US and Europe Surgical Heart Valve Management Products are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Surgical Heart Valve Management Products landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Surgical Heart Valve Management Products include Abbott Laboratories, Becton Dickinson, Medtronic, Biostable Science & Engineering, C.R. Bard, CardiaMed, Cook Medical, CorMatrix Cardiovascular and CryoLife, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Surgical Heart Valve Management Products Scope and Segment
Surgical Heart Valve Management Products market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Surgical Heart Valve Management Products market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Percutaneous Balloon Valvuloplasty 
Heart Valve Surgery 
Heart Valve Repair 
Heart Valve Replacement
Segment by Application
Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratory
By Company
Abbott Laboratories
Becton Dickinson
Medtronic
Biostable Science & Engineering
C.R. Bard
CardiaMed
Cook Medical
CorMatrix Cardiovascular
CryoLife
Edwards Lifesciences
Genesee Biomedical
Labcor
Lepu Medical
LivaNova
Medtentia
NuMed
ON-X Life Technologies
Osypka
Venus Medtech
TTK Healthcare
Wyss Institute
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E